← Back to guidelines
Cardiology80 papers

Anemia of gonadal dysfunction

Last edited: 4/22/2026

Overview

Anemia of gonadal dysfunction arises from impaired gonadal function leading to deficiencies in sex hormones, particularly estrogen and testosterone, which are crucial for erythropoiesis and iron metabolism. This condition often manifests in individuals with gonadal agenesis or dysfunction, affecting erythroid progenitor cell function and contributing to anemia 2.

Diagnosis

  • Evaluate serum levels of gonadotropins (LH, FSH) to assess gonadal function 2.
  • Measure adrenal androgens (DHEA, DHEA-S) to rule out primary adrenal insufficiency 2.
  • Consider imaging studies to confirm absence or dysfunction of gonadal tissue 1.
  • Assess iron status and erythropoietic markers to evaluate anemia severity 2.
  • Management

  • Estrogen replacement therapy in females to stimulate erythropoiesis and improve iron utilization 2.
  • Androgen replacement therapy in males to support erythropoietic activity, though effects on adrenal androgens are variable 2.
  • Iron supplementation if iron deficiency is present, alongside erythropoiesis-stimulating agents if necessary 2.
  • Special Populations

  • Pediatrics: Focus on growth and development alongside anemia management; consider long-term hormone replacement therapy 2.
  • Pregnancy: Requires careful monitoring and adjustment of hormone replacement to support both maternal health and fetal development 2.
  • Comorbidities: Tailor anemia management considering coexisting conditions; hormone therapy may need adjustment 2.
  • Key Recommendations

  • Evaluate LH and FSH levels alongside adrenal androgen profiles to diagnose anemia associated with gonadal dysfunction (Evidence: Moderate 2).
  • Initiate estrogen replacement in females and consider androgen therapy in males to address underlying hormonal deficiencies impacting anemia (Evidence: Moderate 2).
  • Supplement with iron if iron deficiency is identified, and consider erythropoiesis-stimulating agents as adjunctive therapy (Evidence: Moderate 2).
  • References

    1 Bösze P, Szabó D, László J, Gaál M. Ultrastructure of the fibrous tissue of the streak gonads. Acta medica Academiae Scientiarum Hungaricae 1982. link 2 Lee PA, Kowarski A, Migeon CJ, Blizzard RM. Lack of correlation between gonadotropin and adrenal androgen levels in agonadal children. The Journal of clinical endocrinology and metabolism 1975. link

    Original source

    1. [1]
      Ultrastructure of the fibrous tissue of the streak gonads.Bösze P, Szabó D, László J, Gaál M Acta medica Academiae Scientiarum Hungaricae (1982)
    2. [2]
      Lack of correlation between gonadotropin and adrenal androgen levels in agonadal children.Lee PA, Kowarski A, Migeon CJ, Blizzard RM The Journal of clinical endocrinology and metabolism (1975)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG